PPARG and inflammatory bowel disease: Inflammatory stimuli induced the higher expression of nitric oxide synthase (iNOS) and oxidative stress enzymes in macrophages, as well as the release of pro‐inflammatory cytokines in the inflammatory colon lumen.[18, 19] ROSI, an agonist of peroxisome proliferator activated receptor gamma (PPAR‐γ) with anti‐inflammatory effect was encapsulated into Effero‐RLP for IBD treatment.[20] Collectively, efferocytosis based biomimetic nanoparticle was a promising way for anti‐inflammation.